麻豆国产av超爽剧情系列-波多野结衣电影在线播放-国产1页-美女视频黄色-在线观看欧美日韩-久久久久久久网-日本不卡在线播放-免费在线观看的av-色噜噜狠狠一区二区三区果冻-中文精品一区-亚洲影视在线观看-精品在线视频一区-在线播放第一页-日韩午夜免费-热久久最新网址-免费看的一级片-日本高清中文-日日爱99-自拍视频网址-精品少妇一区二区三区密爱-久久网一区-最新中文在线-在线视频这里只有精品-久久久久久无码精品人妻一区二区-国产精品福利网

Language:簡體 / 繁體 / English

Luoxin Pharmaceutical,Source of Health


Luoxin Pharmaceutical,Source of Health

Luoxin Pharmaceutical,Source of Health


Luoxin Pharmaceutical,Source of Health

R&D Strategy


The Group adheres to the strategic concept of “science and technology driven development” and implements the product R&D strategy of “looking into the future, focusing on the present and creation-imitation running in parallel”. Based on high-tech products, linked by strict and standardized management and guaranteed by high quality, it actively creates brand products with the tool of science and technology to enhance the reputation of the enterprise which is rewarded with better sales performance. It has also established the strategy of “one-generation production, one-generation reserve, one-generation research” in terms of high-tech products, continuously launches “three-high” products (high-tech, high-quality, high value-added), laying a solid product foundation for sustainable development of the enterprise.


Presently, the Group has over 300 scientific researchers, among which, over 100 are doctors and masters. It actively practices industry-university-research strategy and has built long-term stable cooperative relation with over 30 universities and research institutes nationwide. In this way, new products and technologies are continuously injected into Luoxin to improve the research and development of drugs.